Circulating miR-125a but not miR-125b is decreased in active disease status and negatively correlates with disease severity as well as inflammatory cytokines in patients with Crohn’s disease

Figure 3 Correlations of miR-125a/b expression with disease severity in active Crohn's disease patients. A-C: Correlations of miR-125a expression with disease severity in A-CD patients; D-F: Correlations of miR-125b expression with disease severity in A-CD patients. Spearman’s test was used to analyse the correlation of miR-125a/b expression with disease severity. P < 0.05 was considered significant. A-CD: Active Crohn's disease; R-CD: Crohn's disease in remission; HCs: Healthy controls.